Abstract CT136: Phase Ib study of Decitabine in combination with Gemcitabine in treatment of refractory pancreatic adenocarcinoma and advanced soft tissue or bone sarcomas
Laith Abushahin(The Ohio State University), Mohammed Milhem(University of Iowa), Munir R. Tanas(Veterans Health Administration), Sarah L. Mott(University of Iowa), Chandrikha Chandrasekharan(University of Iowa Hospitals and Clinics), Michael D. Henry(University of Iowa), Mariel Mckay(University of Iowa Hospitals and Clinics), Varum Monga(University of Iowa Hospitals and Clinics), Daniel Berg(Erasmus MC)
Cited by 2
Related Papers
Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma
|New England Journal of Medicine|2021|869
Identification of a Disease-Defining Gene Fusion in Epithelioid Hemangioendothelioma
|Science Translational Medicine|2011|401
Disruption of Dag1 in Differentiated Skeletal Muscle Reveals a Role for Dystroglycan in Muscle Regeneration
|Cell|2002|297
Sarcopenia is an independent predictor of complications following pancreatectomy for adenocarcinoma
|Journal of Surgical Oncology|2014|274